Surgical Procedures and Morbidities of Diaphragmatic Surgery in Patients Undergoing Initial or Interval Debulking Surgery for Advanced-Stage Ovarian Cancer

Journal of the American College of Surgeons

Volumn 210, Issue 4, 2010, Pages 509-514

  Gouy, Sebastien ^a   Chereau, Elisabeth ^a   Custodio, Ana Sofia ^a   Uzan, Catherine ^a   Pautier, Patricia ^a   Haie Meder, Christine ^a   Duvillard, Pierre ^a   Morice, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAPHRAGMATIC SURGERY; FEMALE; HUMAN; LUNG COMPLICATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; THORAX DRAINAGE; TUBE;

ABDOMINAL ABSCESS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-125 ANTIGEN; CHEMOTHERAPY, ADJUVANT; CHEST TUBES; CLINICAL COMPETENCE; DIAPHRAGM; DIGESTIVE SYSTEM FISTULA; FEMALE; HEMATOMA; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PATIENT CARE TEAM; PERITONEAL NEOPLASMS; PLEURAL EFFUSION; PNEUMOTHORAX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; REOPERATION; RETROSPECTIVE STUDIES; SECOND-LOOK SURGERY; SURGICAL WOUND DEHISCENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 77949876889     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.01.011     Document Type: Article

References (21)

1. Du Bois A., Reuss A., Pujade-Lauraine E., et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 115 (2009) 1234-1244
2. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol (2002) 1248-1259
3. Chi D.S., Eisenhauer E.L., Lang J., et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol Oncol 103 (2006) 559-564
4. Tangjitgamol S., Manusirivithaya S., Laopaiboon M., and Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol 112 (2009) 257-264
5. Berman M.L. Future directions in the surgical management of ovarian cancer. Gynecol Oncol 90 (2003) 224-230
6. Covens A.L. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 78 (2000) 269-274
7. Deppe G., Malviya V.K., Boike G., and Hampton A. Surgical approach to diaphragmatic metastases from ovarian cancer. Gynecol Oncol 24 (1986) 258-260
8. Montz F.J., Schlaerth J.B., and Berek J.S. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 35 (1989) 338-340
9. Kapnick S.J., Griffiths C.T., and Finkler N.J. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol Oncol 39 (1990) 135-138
10. Eisenhauer E.L., D'Angelica M.I., Abu-Rustum N.R., et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol 103 (2006) 871-877
11. Dowdy S.C., Loewen R.T., Aletti G., et al. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol 109 (2008) 303-307
12. Devolder K., Amant F., Neven P., et al. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer 18 (2008) 363-368
13. Chereau E., Ballester M., Selle F., et al. Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer. BJOG 116 (2009) 1062-1068
14. Einenkel J., Ott R., Handzel R., et al. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer. Int J Gynecol Cancer 19 (2009) 1288-1297
15. Morice P., Brehier-Ollive D., Rey A., et al. Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study. Ann Oncol 14 (2003) 74-77
16. Lee S.J., Kim B.G., Lee J.W., et al. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. J Obstet Gynaecol Res 32 (2006) 99-106
17. th Meeting of the International Gynecologic Cancer Society, October 25-28, 2008.
18. Colombo P.E., Mourregot A., Fabbro M., et al. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients. EJSO 35 (2009) 135-143
19. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 100 (2006) 283
20. Ghaferi A.A., Birkmeyer J.D., and Dimick J.B. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 361 (2009) 1368-1375
21. Carayon P., and Gürses A.P. A human factors engineering conceptual framework of nursing workload and patient safety in intensive care units. Intensive Crit Care Nurs 21 (2005) 284-301